A Computational Neuroscience Perspective on the Shared Social Cognitive Deficits of Autism and Schizophrenia
1 other identifier
observational
267
1 country
1
Brief Summary
This retrospective cohort study will examine shared neural mechanisms of social cognitive deficits in adults with autism spectrum disorder and adults with schizophrenia using existing clinical, behavioral, and neuroimaging data from National Taiwan University Hospital cohort studies. The study will include adults with autism spectrum disorder, adults with schizophrenia, and healthy control participants. Resting-state functional magnetic resonance imaging (MRI) and structural MRI data will be analyzed to estimate default mode network functional transition indices. These indices will be compared between diagnostic groups and examined in association with social cognitive and psychiatric symptom measures, including the Social Responsiveness Scale (SRS) and the Positive and Negative Syndrome Scale (PANSS) when applicable. No new participants will be recruited, and no intervention will be administered. The study will use previously collected data from 80 adults with autism spectrum disorder, 79 adults with schizophrenia, and 108 healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2025
CompletedFirst Submitted
Initial submission to the registry
May 24, 2026
CompletedFirst Posted
Study publicly available on registry
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 23, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 8, 2026
May 1, 2026
10 months
May 24, 2026
June 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Default Mode Network mean functional state transition velocity, DMNμV
DMNμV will be derived from resting-state functional MRI data. Multi-voxel activity patterns within the default mode network will be projected into a two-dimensional state space using multidimensional scaling. The Euclidean distance between consecutive functional states will be calculated, and the mean transition velocity across time points will be used as an index of default mode network functional state stability. Lower DMNμV indicates slower state transition and higher functional state stability.
Baseline / retrospective assessment from pre-existing resting-state fMRI data
Secondary Outcomes (3)
Default Mode Network Root Mean Square of Successive Differences
Baseline / retrospective assessment from existing resting-state fMRI data
Social Responsiveness Scale Score, SRS
Baseline / retrospective assessment from existing source cohort records
Positive and Negative Syndrome Scale Score, PANSS
Baseline / retrospective assessment from existing source cohort records
Study Arms (3)
Healthy controls
Autism Spectrum Disorder
Schizophrenia
Eligibility Criteria
This retrospective cohort study will use pre-existing clinical, behavioral, and neuroimaging data from adult participants who were previously enrolled in cohort studies conducted at National Taiwan University Hospital. The study population includes adults with autism spectrum disorder, adults with schizophrenia, and healthy control participants. Available data include structural MRI, resting-state functional MRI, and symptom or behavioral assessments relevant to social cognition and psychiatric symptoms, including the Social Responsiveness Scale and the Positive and Negative Syndrome Scale when applicable. No new participants will be prospectively recruited, and no intervention will be administered.
You may qualify if:
- Previously enrolled in one of the source cohort studies approved by the institutional review board of National Taiwan University Hospital.
- Adult participants belonging to one of the following groups:
- Autism spectrum disorder group: participants with a clinical diagnosis of autism spectrum disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
- Schizophrenia group: participants with a clinical diagnosis of schizophrenia according to DSM-5 criteria.
- Healthy control group: participants without a history of autism spectrum disorder, schizophrenia, or other major psychiatric or neurodevelopmental disorders according to available source cohort records.
- Availability of resting-state functional MRI data acquired under the study MRI protocol.
- For participants in the autism spectrum disorder group, availability of autistic trait or social functioning measures, such as the Social Responsiveness Scale, when used in symptom-association analyses.
- For participants in the schizophrenia group, availability of psychiatric symptom measures, such as the Positive and Negative Syndrome Scale, when used in symptom-association analyses.
You may not qualify if:
- Missing or incomplete MRI data.
- Poor-quality MRI data due to severe artifacts, failed preprocessing, failed registration, or incomplete brain coverage.
- Excessive head motion during resting-state fMRI that prevents reliable analysis.
- Missing essential demographic or diagnostic information.
- Missing required clinical or behavioral measures for specific association analyses.
- Healthy controls with documented major psychiatric or neurodevelopmental disorders, if identified in source cohort records.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2026
First Posted
June 1, 2026
Study Start
September 30, 2025
Primary Completion (Estimated)
July 23, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
June 8, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share